Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Harvard Bioscience (HBIO) Restructuring Costs (2016 - 2025)

Historic Restructuring Costs for Harvard Bioscience (HBIO) over the last 11 years, with Q3 2025 value amounting to $48000.0.

  • Harvard Bioscience's Restructuring Costs fell 7318.44% to $48000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $350000.0, marking a year-over-year decrease of 3913.04%. This contributed to the annual value of -$233000.0 for FY2022, which is N/A changed from last year.
  • Per Harvard Bioscience's latest filing, its Restructuring Costs stood at $48000.0 for Q3 2025, which was down 7318.44% from $30000.0 recorded in Q2 2025.
  • Harvard Bioscience's Restructuring Costs' 5-year high stood at $5.2 million during Q1 2022, with a 5-year trough of -$4.9 million in Q2 2022.
  • For the 3-year period, Harvard Bioscience's Restructuring Costs averaged around $64125.0, with its median value being $70500.0 (2025).
  • Over the last 5 years, Harvard Bioscience's Restructuring Costs had its largest YoY gain of 7318.44% in 2025, and its largest YoY loss of 9242.42% in 2025.
  • Harvard Bioscience's Restructuring Costs (Quarter) stood at -$544000.0 in 2022, then surged by 132.9% to $179000.0 in 2024, then crashed by 73.18% to $48000.0 in 2025.
  • Its Restructuring Costs stands at $48000.0 for Q3 2025, versus $30000.0 for Q2 2025 and $93000.0 for Q1 2025.